Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review

Cancers (Basel). 2023 Jan 3;15(1):324. doi: 10.3390/cancers15010324.

Abstract

Growing evidence suggests that, among the different molecular/cellular pathophysiological mechanisms associated with cancer, there are 14 hallmarks that play a major role, including: (i) sustaining proliferative signaling, (ii) evading growth suppressors, (iii) activating invasion and metastasis, (iv) enabling replicative immortality, (v) inducing angiogenesis, (vi) resisting cell death, (vii) reprogramming energy metabolism, (viii) evading immune destruction, (ix) genome instability and mutations, (x) tumor-promoting inflammation, (xi) unlocking phenotypic plasticity, (xii) nonmutational epigenetic reprogramming, (xiii) polymorphic microbiomes, and (xiv) senescent cells. These hallmarks are also associated with the development of breast cancer, which represents the most prevalent tumor type in the world. The present narrative review aims to describe, for the first time, the effects of physical activity/exercise on these hallmarks. In summary, an active lifestyle, and particularly regular physical exercise, provides beneficial effects on all major hallmarks associated with breast cancer, and might therefore help to counteract the progression of the disease or its associated burden.

Keywords: biomarkers; breast cancer; mammary cancer; physical activity; training.

Publication types

  • Review

Grants and funding

This research received no external funding. Research by S.L.-O. is funded by the Spanish Ministry of Science and Innovation (grant number FPU19/02117). Research by S.P.-G. is funded by the Spanish Ministry of Science and Innovation (grant number FPU20/07594). Research by CFL and PLV is funded by postdoctoral contracts granted by Instituto de Salud Carlos III (Miguel Servet CP18/00034 and Sara Borrell CD21/00138 respectively). Research by AL and CFL is funded by the Spanish Ministry of Economy and Competitiveness and Fondos FEDER (grants #PI18/00139 and PI20/00605) and by the Wereld Kanker Onderzoek Fonds, as part of the World Cancer Research Fund International grant programme (grant #IIG_FULL_2021_007).